Related Experiment Video

Updated: Mar 16, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

18.4K

Immunoproteasomes and immunotherapy-a smoking gun for lung cancer?

Menno Spits1, Jacques Neefjes1

  • 1Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, NL, The Netherlands;; Department of Chemical Immunology, Leiden University Medical Center LUMC, Leiden, NL, The Netherlands.

Journal of Thoracic Disease
|August 9, 2016
PubMed

Insights

Immunotherapy offers a new treatment for non-small cell lung cancer (NSCLC), a prevalent cancer with poor prognosis. Modifying immunoproteasomes may enhance immune response and identify patients who will benefit from immunotherapy.

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • Lung cancer is a leading cause of cancer death, with non-small cell lung cancer (NSCLC) comprising the majority of cases.
  • Patients with NSCLC often face a poor prognosis, necessitating novel therapeutic strategies.
  • Immunotherapy has emerged as a promising treatment, significantly improving outcomes for some NSCLC patients.

Discussion:

  • This review explores various forms of immunotherapy for NSCLC.
  • It examines how immune modification of proteasomes can bolster the immune system's ability to combat NSCLC.
  • The role of immunoproteasomes in enhancing NSCLC recognition and their potential as predictive biomarkers is discussed.

Key Insights:

  • Immunoproteasomes play a crucial role in the immune system's recognition of non-small cell lung cancer.
  • Modulating immunoproteasomes presents a potential strategy to enhance the efficacy of immunotherapy in NSCLC.
  • Immunoproteasomes may serve as valuable biomarkers for patient selection in immunotherapy treatment.

Outlook:

  • Further research into immunoproteasome function could lead to optimized immunotherapy protocols for NSCLC.
  • Identifying patients with specific immunoproteasome profiles may improve treatment response rates.
  • This approach holds promise for personalized medicine in non-small cell lung cancer treatment.
Keywords:
Non-small cell lung cancer (NSCLC)checkpoint antibodiesimmunoproteasomeimmunotherapytumor infiltrating lymphocyte therapy (TILT)

More Related Videos

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

2.0K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.9K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K